Once- versus twice-daily aspirin treatment in patients with essential thrombocytosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Once- versus twice-daily aspirin treatment in patients with essential thrombocytosis
Authors
Keywords
-
Journal
PLATELETS
Volume -, Issue -, Pages 1-7
Publisher
Informa UK Limited
Online
2018-02-14
DOI
10.1080/09537104.2018.1430356
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The prevalence and factors associated with aspirin resistance in patients premedicated with aspirin
- (2017) Sayer I. Al-Azzam et al. ACTA CARDIOLOGICA
- Assessment of rotation thromboelastometry parameters in patients with essential thrombocythemia at diagnosis and after hydroxyurea therapy
- (2016) Jacek Treliński et al. BLOOD COAGULATION & FIBRINOLYSIS
- The Effects of Different Aspirin Dosing Frequencies and the Timing of Aspirin Intake in Primary and Secondary Prevention of Cardiovascular Disease: A Systematic Review
- (2016) D Bem et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Hydroxyurea Increases Plasma Concentrations of Microparticles and Reduces Coagulation Activation and Fibrinolysis in Patients with Sickle Cell Anemia
- (2015) Denise Menezes Brunetta et al. ACTA HAEMATOLOGICA
- Antiplatelet drugs in patients with enhanced platelet turnover: biomarkers versus platelet function testing
- (2015) Susanne Gruber et al. THROMBOSIS AND HAEMOSTASIS
- 24-hour antiplatelet effect of aspirin in patients with previous definite stent thrombosis
- (2014) Morten Würtz et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Aspirin Therapy in Primary Cardiovascular Disease Prevention
- (2014) Sigrun Halvorsen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease
- (2012) Jean-Guillaume Dillinger et al. AMERICAN HEART JOURNAL
- Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target
- (2012) S. Pascale et al. BLOOD
- Interindividual Variability in the Efficacy of Oral Antiplatelet Drugs: Definitions, Mechanisms and Clinical Importance
- (2012) Morten Wurtz et al. CURRENT PHARMACEUTICAL DESIGN
- Platelet Function Testing in Atherothrombotic Disease
- (2012) Erik Lerkevang Grove et al. CURRENT PHARMACEUTICAL DESIGN
- Aspirin twice a day keeps new COX-1 at bay
- (2012) M. LORDKIPANIDZÉ et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes
- (2012) B. ROCCA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Advances in monitoring of aspirin therapy
- (2012) Marie Lordkipanidzé PLATELETS
- Direct evidence for normalization of platelet function resulting from platelet count reduction in essential thrombocythemia
- (2011) Argirios E. Tsantes et al. BLOOD COAGULATION & FIBRINOLYSIS
- Antiplatelet agents for the treatment and prevention of atherothrombosis
- (2011) Carlo Patrono et al. EUROPEAN HEART JOURNAL
- Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
- Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications
- (2011) Galia Spectre et al. THROMBOSIS AND HAEMOSTASIS
- Platelet aggregation is dependent on platelet count in patients with coronary artery disease
- (2011) Morten Würtz et al. THROMBOSIS RESEARCH
- Twice daily aspirin to improve biological aspirin efficacy in patients with essential thrombocytemia
- (2011) Jean-Guillaume Dillinger et al. THROMBOSIS RESEARCH
- Patients With Previous Definite Stent Thrombosis Have a Reduced Antiplatelet Effect of Aspirin and a Larger Fraction of Immature Platelets
- (2010) Morten Würtz et al. JACC-Cardiovascular Interventions
- Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease
- (2010) E. L. GROVE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease
- (2010) Anne-Mette Hvas et al. THROMBOSIS AND HAEMOSTASIS
- 24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease
- (2010) Adeline Vermillet et al. THROMBOSIS AND HAEMOSTASIS
- The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy
- (2009) A. Dragani et al. BLOOD
- Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays
- (2009) Francesca Santilli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: Relationship with thrombosis occurrence andJAK2 V617F allele burden
- (2008) Eduardo Arellano-Rodrigo et al. AMERICAN JOURNAL OF HEMATOLOGY
- The 2008 WHO diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis
- (2008) Juergen Thiele et al. Current Hematologic Malignancy Reports
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started